Healthcare and Life Sciences Consulting Global M&A Report 2018

Our review of deal flow in the healthcare and life sciences consulting space shows rising demand from cash-rich strategic and financial buyers for larger acquisition opportunities

By Ramone Param, Director

Published today, Equiteq’s healthcare and life sciences consulting global M&A report provides exclusive acquisition and valuation insights for consulting firm owners considering a sale. The data reviews M&A, investor and equity market activity in 2017, as well as over the last ten-years. Our unique insights are informed by our regular detailed conversations with the leading serial acquirers of healthcare and life sciences consulting businesses. The following is a brief overview of the key themes from the report, the full version of which can be found here.

Healthcare M&A activity at a glance

  • 371 completed deals in 2017, down 12% year-on-year
  • Median deal value of $21m, up 14% year-on-year
  • 24% of deals were cross-border
  • The Equiteq Healthcare Consulting Share Price Index rose 28%, while the S&P 500 gained 18%

There were large variations in deal flow among healthcare consulting segments, with stronger activity occurring in spaces like data & analytics and strategy consulting to life sciences companies. The number of completed deals fell, but the median size of transaction rose substantially, indicating that buyers were focused on a smaller number of larger deals.

Continue reading

Healthcare Consulting Insights: Healthcare Provider Consulting M&A

By Nicodemo Esposito, Managing Director and Ramone Param, Director

M&A activity is strong for specialized operational management consulting businesses that provide innovative, data-driven process improvement and cost reduction solutions

We continue to receive feedback from the most prolific buyers of knowledge-intensive services firms that expertise in helping healthcare providers with process improvement and operational efficiency is of high strategic importance for growth. A confluence of demographic, economic and regulatory drivers are forcing providers to improve care standards and enable efficiencies. Providers are also increasingly being compelled to invest in new digital technologies that can create data-driven productivity improvements and competitive advantages. These industry trends are driving strong demand and premium valuations for well-positioned operational consulting firms working with healthcare providers. Equiteq experienced this demand first hand in its sale of c3/consulting to Ankura. c3 has a track record of providing management consulting services to a variety of leading healthcare organizations in the US.

Continue reading

Healthcare Consulting Insights: Life sciences strategy consulting M&A

By Matt Hasson, Managing Director and Ramone Param, Director

Buyers are paying premiums for specialized strategy consulting businesses that provide impactful product commercialization solutions for life sciences companies

Based on our in-depth discussions with global buyers and the recent flurry of M&A activity, acquisition demand for life sciences strategy consultancies is exceptionally high. Recent landmark acquisitions by both strategic and financial buyers were struck at premium valuation levels – and as the supply of high-quality acquisition targets continues to dwindle, valuation levels of independent consultancies of scale could rise even further.

Continue reading

Equiteq Advised Knowledge Economy M&A Deals: Q1 2018

  • Insight Strategy Advisors joins Precision Value & Health
  • Ducker Worldwide joins Frontier Strategy Group
  • Axentel joins Park Place Technologies
  • 8works joins Oliver Wyman

We have had a strong start to 2018 across regions, advising a variety of knowledge economy clients on their equity growth and closing a number of high-profile transactions. Here we highlight our advisory work with clients which resulted in M&A deal closures during the first quarter.

Continue reading

Equiteq’s Consulting Sector M&A Deals: Q4 2017

  • The BioTech Quality Group joins Assystem S.A.
  • ShiftIN Partners sold to Sia Partners
  • Livingbridge invests in TSA Management
  • Pathway to Your Potential completes strategic alliance with Mercer Australia

Last quarter proved to be a busy one for Equiteq and its clients with consulting deals closing around the world. The following recaps the sale and investment opportunities completed for clients in Q4 2017.


The BioTech Quality Group joins Assystem S.A.
Industry: Life sciences consulting Date: 1 December 2017 Geography: Central Europe

Equiteq facilitated the sale of Life sciences consulting client, The Biotech Quality Group (BQG), to international engineering group, Assystem S.A.

BQG specializes in performance management and regulatory compliance in Europe’s pharmaceutical and biotech industries, and has developed a range of bespoke methods and tools aimed at increasing the maturity and transforming the practices of the (bio)pharmaceutical industry.

The strategic acquisition of BQG significantly moves Assystem forward in the implementation of its Life sciences strategy of becoming a European leader in the areas of commissioning, certification, validation and regulatory compliance in the European pharmaceutical and biotech industries.

The deal is also indicative of the growing volume of life sciences M&A expected to take place in 2018. Recent reports by EY and law firm Baker McKenzie predict a significant increase in deals, with EY estimating 2018 total deal values exceeding $200 billion. According to EY’s report, 60 percent of life sciences executives surveyed in October 2017 plan to actively pursue M&A in the next 12 months, compared with 46 percent in April.

To read our case study on this deal, please click here.

Continue reading

November 2017: Consulting M&A and Equity Market Update

By Ramone Param, Associate Director, Equiteq

  • There was notable deal activity across the knowledge-led services industry.
  • Major deals included Permira’s investment in Duff & Phelps, Navigant’s acquisition of Quorum, PwC’s acquisition of cDecisions and RGP’s acquisition of Accretive Solutions.
  • Equiteq was pleased to advise Livingbridge Australia on their acquisition of TSA Management.
  • The Equiteq Consulting Share Price Index remained stable over the month.

Continue reading